ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country. Read More
Zimbabwe introduces injectable HIV drug
Reading Time: < 1 minute
ZIMBABWE has introduced Cabotegravir long-acting (CAB-LA), an injectable pre-exposure prophylaxis drug, to add to the HIV prevention regime in the country. Read More